MYRX.US Myrexis Inc Cmn Stk

Financial Services Biotechnology USA Stocks
0.0008 USD
Close of Nov 17, 2026
0.0001 0.0070
Market cap
USD 27.6K
P/E
-
P/B
4.42x
ROE
-999.2%
Dividend yield
284,889.24%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2013.

Is MYRX.US undervalued?

Graham number

The Graham number of Myrexis Inc Cmn Stk cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Myrexis Inc Cmn Stk fundamental analysis

No fundamental analysis for Myrexis Inc Cmn Stk yet.

Myrexis Inc Cmn Stk stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Myrexis Inc Cmn Stk

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Full company profile